Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur
Neogene Therapeutics, Inc. , with a $110m series A venture capital round, led a group of five biopharmaceutical companies that revealed $320m in significant VC financings on a single day. The New York